UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER
kmUU300MXic
kmUU300MXic
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Presentations<br />
Beyond Hormone Therapy for Breast Cancer:<br />
Who Needs Targeted Agents?<br />
Authors*: Hope S. Rugo<br />
Abstract #:<br />
Presentation Date/Time: Monday, June 6: 4:45 - 5:05 PM<br />
Location: Hall D1<br />
Education Session: Targeted Therapies in Hormone Receptor-Positive Breast Cancer<br />
Citation:<br />
Rugo Research Interests: Dr. Rugo, Director of Breast Oncology & Clinical Trials Education, is PI on multiple<br />
clinical trials focusing on combining novel targeted therapeutics to improve the treatment of both early &<br />
late stage breast cancer (BC). She also works on studies to improve supportive care for early & late stage<br />
BC patients, including with <strong>UCSF</strong>s Advanced Breast Cancer Program. Dr. Rugo has numerous collaborations<br />
with large academic medical centers & consortia in order to expand the novel therapies available to patients.<br />
She was the director of the 2016 ASCO Breast Cancer Education Committee meeting, is a member of the<br />
Alliance & is a founding member of the Breast Cancer Research Consortium where she co-leads the triple<br />
negative working group. She is on the novel agents committee for the neoadjuvant multi-center I SPY2<br />
trial. At <strong>UCSF</strong>, Dr. Rugo runs the Breast Forum, a bimonthly educational session for breast cancer patients,<br />
families & friends from throughout the bay area.<br />
http://cancer.ucsf.edu/people/profiles/rugo_hope.3648<br />
__________________________________________________________________________<br />
Emerging Insights Into Molecular Profiling<br />
Authors*: Wolfgang Michael Korn<br />
Abstract #:<br />
Presentation Date/Time: Monday, June 6: 5:39 - 5:51 PM<br />
Location: S406<br />
Poster Discussion Session: Tumor Biology<br />
Citation:<br />
Korn Research Interests: Dr. Korn is a physician-scientist focused on the science and management of<br />
gastrointestinal cancers. Furthermore, he is the leader of the <strong>UCSF</strong> Molecular Oncology Initiative and<br />
founding Chair of the <strong>UCSF</strong> Molecular Tumor Board. He is principal investigator of clinical trials exploring<br />
new treatments for gastrointestinal cancers and conducts molecularly driven, disease-independent basket<br />
trials. His laboratory conducts research aimed at developing combination therapies for gastrointestinal<br />
cancers, based on the analysis of signal transduction and DNA repair pathways.<br />
http://cancer.ucsf.edu/gi/michael-korn<br />
*<strong>UCSF</strong> authors in bold<br />
88
Change language